During a webinar on immunity claims sponsored by the Food and Drug Law Institute, Richard Cleland, Assistant Director of FTC's Division of Advertising Practices, confirmed that enforcement actions are in the works against probiotic products that make inadequately substantiated claims. FTC is particularly...
Beginning on October 20, Stoel Rives LLP will present a three-part webinar on “business and legal issues related to the development of environmentally sustainable food products.” The titles and dates for the sessions are: Session 1: Where to Start? Developing and Financing Sustainable Food Produ...
The FDA’s point man on NDI guidance issues, Daniel Fabricant, has been telling the supplement industry what to expect. In a recent webinar he was asked, “Should it be necessary to submit an NDI notification over a small change in the ratios of the long chain omega-3 fatt...
CBD as dietary supplement Some companies have expressed interest in marketing CBD as a dietary supplement. FDA has not issued an opinion or guidance on the issue of whether CBD can be marketed as a supplement, “but reserves the right to take action when appropriate to preserve and protect t...
The NAD recommended Olly discontinue certain claims or modify its advertising for the dietary supplement. The impact of GLP-1 on supplements, functional foods, and retail: a webinar from CRN Erin McEvoy January 30th 2025 Article The recent CRN webinar discussed GLP-1 medications' impact on supplem...
A thought leader in the pharmacologic management of heart failure, Alexandra Goncharenko, PharmD, BCPS, BCCP, reviews the mechanism of action of vericiguat and considers its place in the treatment landscape.
FDA plans to host awebinarto discuss the Draft Guidance. It was originally scheduled for Tuesday, February 18, 2025, but has recently been postponed. Comments on the Draft AI Guidance are due by April 7, 2025. Categories:Medical Devices ...
As a reminder, back in February 2023,HPM bloggedabout DEA’s two proposed rules for prescribing controlled substances generally, and for buprenorphine use in opioid treatment. HPM also conducted a 90-minute webinar addressing the “End of the COVID-19 Emergency and the Ryan Haight Act: Telemedi...
FDA Announces Launch of Center for Tobacco Products; HPM Attorneys to Present Webinar on the Family Smoking Prevention and Tobacco Control ActAugust 20th, 2009 As directed by the Family Smoking Prevention and Tobacco Control Act (“Tobacco Act”), FDA has created its new Center for Tobacco Produc...
The webinar slides can be found here. The … Court Upholds Exclusion of Former Purdue ExecutivesDecember 20th, 2010 By JP Ellison – In Dickens’ A Christmas Carol, the main character is visited by three ghosts who by scaring him with visions of his past, present and future, seek to ...